These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32685913)

  • 1. Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India.
    Bhowmik E; Singh A; Sachan R
    Ther Adv Vaccines Immunother; 2020; 8():2515135520940131. PubMed ID: 32685913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign-A Case of Measles-Rubella and Polio Vaccines.
    Kajungu D; Nambasa V; Muhoozi M; Tusabe J; Kampmann B; Todd J
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Following Immunization Among Children Under Two Years of Age: A Prospective Observational Study From North India.
    Mittal S; Rawat C; Gupta A; Solanki HK; Singh RK
    Cureus; 2023 Apr; 15(4):e38356. PubMed ID: 37266060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran.
    Esteghamati A; Keshtkar A; Heshmat R; Gouya MM; Salar Amoli M; Armin S; Mahoney F
    Arch Iran Med; 2011 Mar; 14(2):91-5. PubMed ID: 21361714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
    Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
    Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data.
    Bellavite P; Donzelli A
    F1000Res; 2020; 9():1176. PubMed ID: 33335717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017-2018.
    Stefanizzi P; Stella P; Ancona D; Malcangi KN; Bianchi FP; De Nitto S; Ferorelli D; Germinario CA; Tafuri S
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31591347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAP perspectives on measles and rubella elimination strategies.
    Vashishtha VM; Yewale VN; Bansal CP; Mehta PJ;
    Indian Pediatr; 2014 Sep; 51(9):719-22. PubMed ID: 25228604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
    Kamble B; Bashar MA; Mishra CP
    Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B; Keisam A; Haobam DS; Thounaojam T
    Indian J Public Health; 2020; 64(2):173-177. PubMed ID: 32584301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
    Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O
    BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital.
    Cherian NM; Durai DA; Jaisel M; Sharma D; Sebastian J; Basavaraja CK; Mathew M
    Ther Adv Vaccines Immunother; 2023; 11():25151355231193975. PubMed ID: 37641637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.
    Lopes SRC; Perin JLR; Prass TS; Carvalho SMD; Lessa SC; Dórea JG
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29865181
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
    Jeon M; Kim J; Oh CE; Lee JY
    J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.